info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Integrated Cardiology Devices Companies

Companies involved in integrated cardiology devices typically specialize in creating medical devices and technology that contribute to the diagnosis, monitoring, and treatment of cardiovascular diseases. These devices often incorporate advanced technologies to provide comprehensive solutions for cardiac care.

Integrated Cardiology Devices Key CompaniesLatest Integrated Cardiology Devices Companies Update

October 2023: Two novel high-sensitivity cardiac biomarkers, NT-proBNP and troponin I, have been introduced and launched worldwide by Mindray, a global producer of medical equipment and solutions. A recent written statement on the launch stated that the new offerings are the result of Mindray's ongoing efforts in developing advanced chemiluminescence immunoassay products. The statement went on to say that the additions enhance Mindray's diverse portfolio of cardiac biomarkers for diagnosing and managing cardiovascular diseases (CVDs). Even though CVDs kill more people than any other cause on Earth, the business stressed the need of early identification. Guidelines include cTnl and NT-proBNP as critical biomarkers for suspected Acute Coronary Syndrome (ACS) and heart failure, according to the statement. They help with therapeutic monitoring, early screening, risk stratification, and quick diagnoses, which can lead to life-saving clinical choices when made quickly.


September 2023: Royal Philips, a world-renowned health technology business, introduced the newest member of their Zenition mobile C-arm series, the Philips Image Guided Therapy Mobile C-arm System 3000 - Zenition 30, in September 2023. The use of mobile C-arms, which are X-ray devices, has become increasingly common in the operating room (OR) for a variety of therapeutic procedures, including those involving the spine, orthopedics, trauma, pain management, and many more. Surgeons are granted additional control by the Zenition 30, allowing them to work more independently and autonomously. With Zenition 30, hospitals may reduce their reliance on support workers, which helps with staff shortages. Surgeons can treat more patients with high-quality treatment thanks to its workflow-enhancing features and superb picture quality. Just recently, Philips debuted its Zenition 10 C-arm, and now they've followed it up with the Zenition 30.List of Integrated Cardiology Devices Key companies in the market

  • Medtronic (US)

  • Boston Scientific Corporation (US)

  • Jude Medical (US)

  • Edwards Lifesciences Corporation (US)

  • Abbott Laboratories (US)

  • Johnson and Johnson (US)

  • Getinge (Sweden)

  • Terumo Corporation (Japan)

  • Lepumedical (Bejing)

  • Acrostak (Switzerland)

  • Koninklijke Philips N.V. (Netherlands)

  • Athenahealth, Inc. (U.S)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.